DOsimetry and Radiation Induced NAusea in Head and Neck Cancers - Trial NCT06341985
Access comprehensive clinical trial information for NCT06341985 through Pure Global AI's free database. This phase not specified trial is sponsored by European Institute of Oncology and is currently Recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 180 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
European Institute of Oncology
Timeline & Enrollment
N/A
Nov 15, 2021
Dec 31, 2024
Primary Outcome
Evaluation of nausea (acute toxicity) using CTCAE V5.0
Summary
This is a prospective cohort study for the analysis of correlation between dosimetric
 parameters and RANV (Radiation Associated Nausea and Vomiting) in patients with head and neck
 cancer undergoing exclusive radiotherapy (RT).
 
 The primary purpose of this study is to search for a potential correlation between dosimetry
 and physician- and patient-rated symptoms in patients treated with exclusive radiotherapy for
 head and neck cancer.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06341985
Non-Device Trial